Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preserving the sanctity of overall survival for drugs approved on the basis of progression-free survival: tivozanib as a case study.

× No keyword cloud information.

4 in total

Review 1. The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell Carcinoma.

Authors: Emiliano Calvo; Camillio Porta; Viktor Grünwald; Bernard Escudier
Journal: Oncologist Date: 2018-08-29

2. Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature.

Authors: Laura Caquelin; Mohamed Gewily; Wendy Mottais; Chloé Tebaldi; Bruno Laviolle; Florian Naudet; Clara Locher
Journal: BMC Cancer Date: 2022-04-09 Impact factor: 4.430

3. Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial.

Authors: Tim Eisen; Eleni Frangou; Bhavna Oza; Alastair W S Ritchie; Benjamin Smith; Rick Kaplan; Ian D Davis; Martin R Stockler; Laurence Albiges; Bernard Escudier; James Larkin; Axel Bex; Steven Joniau; Barry Hancock; Gregers G Hermann; Joaquim Bellmunt; Elizabeth Hodgkinson; Grant D Stewart; Jim Barber; Janet Brown; Rhona McMenemin; Paul Nathan; Lisa M Pickering; Mahesh K B Parmar; Angela Meade
Journal: J Clin Oncol Date: 2020-10-14 Impact factor: 44.544

Review 4. Sequence of treatment in locally advanced and metastatic renal cell carcinoma.

Authors: Stefanie Fischer; Silke Gillessen; Christian Rothermundt
Journal: Transl Androl Urol Date: 2015-06

4 in total